How Long Should You Breastfeed? The Evidence-Based Sweet Spot

What Most People Think

The breastfeeding conversation almost always centres on the baby -- immune system benefits, bonding, cognitive development. When it comes to how long to breastfeed, the debate usually boils down to cultural comfort: "is it weird to breastfeed past 12 months?"

The mother's long-term health barely enters the picture. Most people assume the main benefit for mum is faster postpartum weight loss and some hormonal bonding. Beyond that, it's treated as a neutral act -- helpful for the baby, irrelevant for the mother's future.

What the Evidence Actually Shows

Pregnancy deliberately makes you insulin resistant and raises your cholesterol to feed the growing baby. Breastfeeding reverses this -- it burns roughly 500 calories daily and physically excretes triglycerides and cholesterol through the milk. Women who skip breastfeeding or stop early stay in that elevated metabolic state for longer. HIGH

The dose-response isn't linear. The Nurses' Health Study tracked 166,708 women over 4.7 million person-years and found the mortality sweet spot sits between 12 and 23 months of total lifetime breastfeeding (HR 0.93). They modeled the data with cubic splines and found a clear non-linear U-shaped curve (p=0.0007). Beyond 24 months total, the risk reduction stops improving. HIGH

What would change this: an RCT with continuous glucose monitoring showing metabolic recovery completes within 6 months regardless of continued lactation.

For the baby, the protection is lifelong and causal. A Mendelian randomization study used genetic variants across 814,402 people to bypass socioeconomic confounding. Being breastfed as an infant reduced coronary atherosclerosis risk by 17.4%, with about 10% of that effect mediated by permanently higher HDL cholesterol (Zhang et al., 2025). MODERATE

What would change this: replication in non-European cohorts showing the genetic proxy doesn't hold across ancestries.

Cancer protection scales more aggressively with duration than cardiovascular protection. Women who breastfeed for 12+ months see a 26% lower risk of breast cancer and 37% lower risk of ovarian cancer. Unlike the heart data, the cancer evidence doesn't show a clear plateau at 24 months. HIGH

In the Women's Health Initiative, an average of 35 years had passed since participants had lactated. Those with 7-12 months of lifetime lactation still showed a 28% reduction in cardiovascular disease (HR 0.72). The metabolic reset isn't temporary -- it prints for decades (Schwarz et al., 2009). HIGH

The Debate

Honest Limitations

The Practical Takeaway

If you can breastfeed at all, aim for at least 6 months. This is where the most dramatic metabolic normalization happens. The MySweetheart RCT showed that women who breastfed 6+ months had lower visceral fat, lower inflammation, and better insulin sensitivity at 1 year postpartum.

The strongest long-term protection comes from 12-24 months total across all children. This doesn't mean 12-24 months per child -- it's cumulative lifetime total. Two children breastfed for 6-12 months each hits the optimal window.

Don't push past 24 months total for health reasons alone. The cardiovascular data shows diminishing returns, and some markers actually plateau. If you want to continue for bonding or other reasons, that's fine -- but the health argument weakens past this point.

The Nuance

The cruel biological catch-22. The women who need the metabolic reset most are the ones who struggle to breastfeed. Higher pre-pregnancy BMI reduces odds of sustaining breastfeeding by 17% per 5 kg/m2 increase (Mendelian randomization data). Women with gestational diabetes face delayed milk production and higher C-section rates. The system fails the people it could help the most.

Environment matters more than duration. The insulin-sensitising effects of lactation assume a low-stress environment. Chronic cortisol from pumping in hostile work environments can dysregulate glucose metabolism enough to negate the cardiovascular protection entirely. The controlled trials that show these benefits occurred in systems with dedicated interdisciplinary support -- not the unassisted reality most working mothers face.

Midlife protection, not lifetime immunity. The cardiovascular benefits are robust in women under 65 but diminish or lose statistical significance in older women. Lactation resets midlife metabolism -- it doesn't permanently override the primary drivers of arterial ageing like arterial stiffness and estrogen depletion.

Conviction

The maternal cardiovascular and mortality benefits up to the 24-month threshold are supported by massive statistical power (N > 1.19 million across meta-analyses), consistent dose-response gradients across multiple independent cohorts, biologically plausible mechanisms (lipid excretion, metabolic reset), and Mendelian randomization confirming causal infant effects.

Conviction for extreme prolonged breastfeeding (>24 months) yielding continuous additive health benefits is LOW -- large-scale data shows a plateau or rebound.

Sources

• Tschiderer et al. (2022), J Am Heart Assoc. Systematic review and meta-analysis of 8 prospective cohorts. N=1,192,700. Ever BF vs never: pooled aHR 0.89 CVD, 0.86 CHD, 0.83 fatal CVD.
• Wang et al. (2022), NHS/NHS II Cohorts. N=166,708, 4.7M person-years follow-up. Lifetime duration 12-23 months: HR 0.93 all-cause mortality. Non-linear U-shaped curve (p=0.0007).
• Zhang et al. (2025), Sci Rep. Two-step Mendelian randomization. Discovery N=346,821, Replication N=467,581. Genetically proxied BF lowered coronary atherosclerosis OR 0.826 (p=0.004). HDL-C mediated 10.26%.
• Kramer et al. (2001/2015), JAMA (PROBIT Trial). Cluster-RCT. N=17,046 mother-infant pairs. Intervention group: 43.3% vs 6.4% exclusive BF at 3 months. Lower infant GI infection (aOR 0.60).
• Schwarz et al. (2009), Obstet Gynecol (WHI OS/CT). N=139,681 postmenopausal women. >12 months lifetime lactation: lower HTN (OR 0.88), diabetes (OR 0.80), hyperlipidemia (OR 0.81).

Need help with nutrition or training? Work with SLH Fit